In the present study, we reported that Mas activation promoted hematoma resolution, attenuated neuroinflammation and alleviated neurological dysfunction through regulation of microglial functional phenotype via the Akt/Nrf2 signaling pathway following ICH. Here, MAS1 is linked to hematoma.